California Specialty Pharmacy and our three ambulatory infusion centers are fully operational and experiencing no disruptions to service. If you are a current patient affected by the fires, please contact us at 8775950757 so we can ensure you receive your medication. If you are not a current patient and are seeking specialty medication support, our team is here to assist. Please reach out at 877.602.7779. Stay safe, and know that we are here for you.

Blog

Our blog is your go-to source for timely updates, valuable insights, and expert advice. Whether you’re a patient, partner, or payor, explore a wide range of topics curated by our dedicated team to keep you informed and empowered.
a woman rides her bike by the river
Looking up at tall palm trees against a deep blue sky

What to Consider When Choosing a Site of Care

What to Consider When Choosing a Site of Care Site of care selection is a critical component in improving outcomes and managing total cost of care. Whether delivering biologics, specialty injectables, or infusion therapies, the setting matters—clinically, operationally, and financially. Moving appropriate therapies from high-cost hospital settings to home or ambulatory infusion centers may reduce costs, support adherence, and maintain consistent quality. With the right partners and infrastructure, alternate sites of care support personalized, guideline-driven treatment while easing pressure on health systems and streamlining patient access. What Does ‘Site of Care’ Mean? The term “site of care” might sound clinical, but it’s simply the physical location where medical treatments are

Read More »
Older woman petting a dog at home on a beautiful day

How Biosimilar Cost Savings Benefit Health Systems

How Biosimilar Cost Savings Benefit Health Systems Biosimilars offer a compelling opportunity for healthcare organizations to manage rising costs while maintaining high-quality care. These therapies, comparable to already approved biologic drugs, can generate significant cost savings without compromising clinical outcomes. The most direct financial impact is often felt by patients and payors, with lower out-of-pocket costs and reduced therapy expenditures. At the same time, health systems and providers benefit from the clinical value—biosimilars deliver outcomes with no clinical difference as compared to reference biologics, ensuring that care quality is not compromised.  For decision-makers, understanding the role of biosimilars is essential. Their adoption can help optimize therapy access, strengthen formulary management,

Read More »
Woman nurse adjusting an IV drop

The Benefits of Patient Adherence Programs for Healthcare Providers

The Benefits of a Patient Adherence Program For Healthcare Providers Medication adherence is a persistent challenge in specialty care. Complex dosing schedules, therapy side effects, and the high cost of specialty medications may prevent patients from following prescribed treatment plans, impacting both clinical outcomes and the cost of care. A structured adherence program addresses these challenges directly. By providing end-to-end support, including financial navigation, therapy monitoring, and side-effect management, these programs help maintain treatment continuity and improve overall effectiveness. For providers, payors, and health systems, the value is clear: stronger clinical outcomes, reduced avoidable hospitalizations, and enhanced alignment across the care continuum. The Challenge of Medication Adherence in Specialty Medication

Read More »
Wave breaking and creating a perfect tunnel

How to Streamline the Pharmacy Claims Processing Workflow in Specialty Care

How to Streamline the Pharmacy Claims Processing Workflow in Specialty Care Navigating pharmacy claims in specialty care is far from straightforward. For healthcare providers, payors, and health systems, every prescription represents not just a treatment plan but a series of coordinated steps that must align perfectly to ensure timely therapy delivery. Even small errors—missing documentation, coverage misunderstandings, or delays in prior authorizations—can cascade into longer treatment start times and frustrated patients. A well-structured pharmacy claims processing workflow isn’t just a procedural necessity—it’s a critical component of delivering high-quality care. Streamlined workflows reduce friction, minimize errors, and create predictability for both patients and providers. For specialty therapies, where medications are high-cost,

Read More »
Happy older man playing chess

How to Optimize the Benefit Investigation Process to Support Patient Access and Costs

How to Optimize the Benefit Investigation Process to Support Patient Access and Costs Benefit investigation is a critical process for specialty therapies, providing clarity on insurance coverage and reimbursement requirements. By identifying coverage details upfront, providers and payors can reduce delays, anticipate potential costs, and ensure timely access to therapies. This process supports both operational efficiency and financial predictability. Accurate benefit investigation enables care teams to plan therapy delivery, coordinate prior authorizations, and manage site-of-care decisions with confidence. It also helps safeguard high-quality care by ensuring patients receive appropriate therapies without avoidable interruptions. By integrating benefit investigation into specialty pharmacy workflows, healthcare organizations gain seamless, end-to-end support. Transparent communication, efficient

Read More »
a couple stops figure out where they are on a hiking trail

What is Alpha-1 Antitrypsin Deficiency?

What is Alpha-1 Antitrypsin Deficiency? Alpha-1 Antitrypsin Deficiency—often just called AATD—is a genetic condition that can affect the lungs and liver. It happens when your body doesn’t make enough of a certain protein (alpha-1 antitrypsin) that helps protect these organs from damage. Without enough of this protein, the lungs and liver become more vulnerable over time. While it may sound overwhelming, you’re not alone—and understanding the basics is the first step toward managing it. Common signs include shortness of breath, frequent lung infections, or liver problems, though symptoms can vary from person to person. The good news is that an early diagnosis and the right care can make a big

Read More »
a woman relaxes and scrolls on her phone

IVIG Treatment for CIDP in Clinical Practice

IVIG for CIDP in Clinical Practice Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) is a rare autoimmune disorder that damages peripheral nerves, leading to muscle weakness, numbness, and impaired function. Intravenous Immunoglobulin (IVIG) has emerged as an effective therapy, providing targeted antibodies to reduce inflammation and support nerve repair. Regular IVIG infusions have been shown to improve functional outcomes, enhance mobility, and support long-term disease management. For healthcare providers and specialty pharmacies, understanding IVIG protocols, infusion scheduling, and patient monitoring is critical to delivering consistent, high-quality care for individuals with CIDP. Who May Benefit from IVIG Therapy? Not all patients with chronic inflammatory demyelinating polyneuropathy (CIDP) respond equally to IVIG therapy. Those

Read More »
a doctor helps a patient with a question

Enhancing Oncology Care Through IVIG Cancer Treatment

Enhancing Oncology Care Through IVIG Cancer Treatment Intravenous immunoglobulin (IVIG) therapy is a critical tool for supporting oncology patients whose immune systems are compromised by cancer or its treatments. By supplementing the body with concentrated antibodies, IVIG reduces infection risk, manages autoimmune complications, and helps maintain adherence to complex cancer care regimens. For health systems, infusion centers, and specialty partners, understanding both the clinical applications and operational considerations of IVIG is essential to delivering safe, timely, and effective therapy that supports optimal patient outcomes. Clinical Applications and Evidence of IVIG in Oncology IVIG therapy provides targeted immune support for cancer patients whose immune systems are compromised by disease or treatment.

Read More »
Infusion drip

IVIG for GBS Treatment and Prognosis in Clinical Practice

IVIG for GBS Treatment and Prognosis in Clinical Practice Intravenous immunoglobulin (IVIG) therapy remains the cornerstone of Guillain-Barré Syndrome (GBS) management, significantly improving functional recovery and reducing long-term complications. This immune-mediated condition can progress rapidly, making early and efficient access to IVIG essential for optimal outcomes. IVIG treatment for GBS delivers concentrated antibodies that help regulate immune activity and prevent further nerve damage. Patients who receive IVIG early on after symptom onset may experience faster neurological recovery and improved prognosis compared to delayed intervention. For healthcare organizations, effective IVIG delivery requires coordination across prescribers, infusion teams, and payors to ensure timely access and continuity of care. Guillain-Barré Syndrome and Its

Read More »
Nurse checking iv

IVIG for Thrombocytopenia

IVIG for Immune Thrombocytopenia (ITP) Each year, nearly 50,000 Americans are diagnosed with immune thrombocytopenia (ITP)—a condition that causes the immune system to mistakenly attack the body’s own platelets, the blood cells responsible for clotting. When platelet counts drop too low, even small cuts or bumps can lead to excessive bruising or bleeding, which can feel worrying and disruptive. To help restore platelet levels and prevent complications, healthcare providers often recommend intravenous immunoglobulin (IVIG). This treatment uses healthy antibodies from donated plasma to calm the immune system’s attack on platelets. For many people, IVIG provides quick, effective relief—helping stabilize platelet counts and allowing them to return to their usual routines

Read More »
Nurse checking iv

IVIG for Thrombocytopenia

IVIG for Immune Thrombocytopenia (ITP) Each year, nearly 50,000 Americans are diagnosed with immune thrombocytopenia (ITP)—a condition that causes the immune system to mistakenly attack

Read More »